In tumours on a background of colitis, loss of Dsc2 was observed in eight of 19 specimens examined, and de novo expression of Dsc1 and Dsc3 was detected in 11 of 19 and six of 19 specimens respectively (Supplementary Table 4). Here, DSC3 is linked to colitis.